Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 3/2021

01-06-2021 | Hereditary Angioedema | Correction

Correction to: Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene

Authors: Jyoti Sharma, Ankur Kumar Jindal, Aaqib Zaffar Banday, Anit Kaur, Amit Rawat, Surjit Singh, Hilary Longhurst

Published in: Clinical Reviews in Allergy & Immunology | Issue 3/2021

Login to get access

Excerpt

    The original version of this article unfortunately contained a mistake. The image of Fig. 1 should be corrected. In the previous figure, we had shown that the plasma kallikrein cleaves both high molecular weight kininogen (HMWK) and low molecular weight kininogen (LMWK) to produce bradykinin. However, the plasma kallikrein activates only high molecular weight kininogen (HMWK) while low molecular weight kininogen (LMWK) is activated by tissue kallikrein. Hence we have removed low molecular weight kininogen (LMWK) in the revised figure. We wish to acknowledge Dr. Allen P. Kaplan, Medical University of South Carolina, Charleston, SC, USA for pointing out the error in Fig. 1. The corrected Fig. 1 is given below. …
Metadata
Title
Correction to: Pathophysiology of Hereditary Angioedema (HAE) Beyond the SERPING1 Gene
Authors
Jyoti Sharma
Ankur Kumar Jindal
Aaqib Zaffar Banday
Anit Kaur
Amit Rawat
Surjit Singh
Hilary Longhurst
Publication date
01-06-2021
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 3/2021
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-021-08849-2

Other articles of this Issue 3/2021

Clinical Reviews in Allergy & Immunology 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine